Huntington National Bank Sells 486 Shares of Bath & Body Works, Inc. (NYSE:BBWI)

Huntington National Bank trimmed its holdings in shares of Bath & Body Works, Inc. (NYSE:BBWI) by 1.9% during the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 25,659 shares of the company’s stock after selling 486 shares during the quarter. Huntington National Bank’s holdings in Bath & Body Works were worth $819,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds have also recently added to or reduced their stakes in the business. First Community Trust NA acquired a new position in shares of Bath & Body Works during the second quarter worth $30,000. Livforsakringsbolaget Skandia Omsesidigt lifted its holdings in Bath & Body Works by 300.0% during the 3rd quarter. Livforsakringsbolaget Skandia Omsesidigt now owns 1,200 shares of the company’s stock worth $38,000 after buying an additional 900 shares during the period. GAMMA Investing LLC lifted its holdings in Bath & Body Works by 65.4% during the 2nd quarter. GAMMA Investing LLC now owns 1,846 shares of the company’s stock worth $72,000 after buying an additional 730 shares during the period. EntryPoint Capital LLC grew its position in shares of Bath & Body Works by 224.0% in the 1st quarter. EntryPoint Capital LLC now owns 1,471 shares of the company’s stock valued at $74,000 after buying an additional 1,017 shares during the last quarter. Finally, Abich Financial Wealth Management LLC acquired a new stake in shares of Bath & Body Works in the third quarter valued at about $103,000. 95.14% of the stock is currently owned by institutional investors and hedge funds.

Bath & Body Works Stock Up 0.7 %

Shares of BBWI opened at $31.54 on Friday. The business’s fifty day moving average is $30.18 and its 200 day moving average is $36.49. Bath & Body Works, Inc. has a 12-month low of $26.20 and a 12-month high of $52.99. The stock has a market cap of $6.91 billion, a P/E ratio of 7.64, a P/E/G ratio of 1.00 and a beta of 1.79.

Bath & Body Works (NYSE:BBWI) last released its quarterly earnings data on Wednesday, August 28th. The company reported $0.37 earnings per share for the quarter, beating analysts’ consensus estimates of $0.35 by $0.02. The firm had revenue of $1.53 billion for the quarter, compared to analyst estimates of $1.54 billion. Bath & Body Works had a net margin of 12.69% and a negative return on equity of 41.94%. On average, analysts expect that Bath & Body Works, Inc. will post 3.18 EPS for the current year.

Bath & Body Works Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Friday, December 6th. Shareholders of record on Friday, November 22nd will be paid a dividend of $0.20 per share. The ex-dividend date is Friday, November 22nd. This represents a $0.80 dividend on an annualized basis and a yield of 2.54%. Bath & Body Works’s dividend payout ratio (DPR) is currently 19.37%.

Insiders Place Their Bets

In other news, CEO Gina Boswell acquired 6,000 shares of the business’s stock in a transaction on Wednesday, October 9th. The shares were purchased at an average cost of $29.64 per share, with a total value of $177,840.00. Following the acquisition, the chief executive officer now directly owns 242,987 shares of the company’s stock, valued at $7,202,134.68. The trade was a 2.53 % increase in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Corporate insiders own 0.27% of the company’s stock.

Wall Street Analysts Forecast Growth

BBWI has been the topic of a number of recent analyst reports. The Goldman Sachs Group cut their price objective on Bath & Body Works from $60.00 to $49.00 and set a “buy” rating on the stock in a research note on Thursday, August 29th. UBS Group reduced their price objective on shares of Bath & Body Works from $52.00 to $38.00 and set a “neutral” rating on the stock in a research note on Thursday, August 29th. Bank of America lowered their target price on shares of Bath & Body Works from $54.00 to $45.00 and set a “buy” rating for the company in a research note on Thursday, August 29th. Raymond James cut their price target on shares of Bath & Body Works from $51.00 to $42.00 and set an “outperform” rating on the stock in a research report on Thursday, August 29th. Finally, Citigroup lowered their price objective on Bath & Body Works from $48.00 to $35.00 and set a “neutral” rating for the company in a research report on Tuesday, August 20th. One equities research analyst has rated the stock with a sell rating, six have issued a hold rating and nine have issued a buy rating to the stock. According to data from MarketBeat, Bath & Body Works has a consensus rating of “Moderate Buy” and a consensus target price of $42.44.

Bath & Body Works Company Profile

Bath & Body Works, Inc operates a specialty retailer of home fragrance, body care, and soaps and sanitizer products. It sells its products under the Bath & Body Works, White Barn, and other brand names through retail stores and e-commerce sites located in the United States and Canada, as well as through international stores operated by partners under franchise, license, and wholesale arrangements.